L'Utile Operativo Cambiamento Data
Acadia Pharmaceuticals USD 71.72M 33.88M 2026-09
Alaunos Therapeutics USD -952K 60K 2026-06
ANI Pharmaceuticals USD 51.84M 12M 2026-09
Ardelyx USD -12.42M 20.37M 2026-06
Aurora Cannabis CAD -8.73M 1.3M 2026-06
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Canopy Growth CAD -17.58M 9.9M 2026-06
Corcept Therapeutics USD 114.72M 73.42M 2026-09
Eli Lilly USD 12.46B 2.68B 2026-06
J&J USD 6.47B 1B 2026-09
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
Merck USD 7.33B 6.49B 2026-09
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Novartis USD 5.14B 392M 2026-09
Novartis USD 1.84B 2.39B 2026-09
Omeros USD -35.41M 23.75M 2024-09
Pacira USD 2.57B 2.56B 2026-09
Pfizer USD 662M 5M 2026-09
Supernus Pharmaceuticals USD -21.04M 14.21M 2026-06
TG Therapeutics USD 21.67M 13.12M 2026-06